Clinical Trial Update: Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating interferon gamma in children with severe congenital osteopetrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopetrosis

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Osteopetrosis | Phase 3 | Status: COMPLETED